Literature DB >> 19104770

Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient.

J H Velthuis1, W W Unger, A R van der Slik, G Duinkerken, M Engelse, A F Schaapherder, J Ringers, C van Kooten, E J de Koning, B O Roep.   

Abstract

AIMS/HYPOTHESIS: Simultaneous kidney-pancreas transplantation is an established treatment for patients with type 1 diabetes and end-stage renal failure, even though restored beta cell function may become affected by recurrent islet autoimmunity or graft rejection. We characterised infiltrating lymphocytes isolated from a pancreatic graft with normal endocrine function in a kidney-pancreas recipient with type 1 diabetes.
METHODS: The pancreas graft was removed due to recurrent graft pancreatitis of unknown cause. Pancreas-infiltrating lymphocytes and peripheral blood mononuclear cells (PBMC) were isolated and characterised phenotypically and functionally.
RESULTS: Compared with PBMC, pancreas-infiltrating lymphocytes exhibited a distinct activation/memory phenotype and T cell receptor profile that were indicative of selective infiltration of the pancreas. Islet autoreactive CD8(+) T cells could be detected in the pancreas and were increased in frequency compared with PBMC. Additionally, an augmentation of CD8(+) CD28(-) regulatory T cells was observed in the pancreas; these induced expression of the inhibitory receptor immunoglobulin-like transcript-3 on antigen-presenting cells in a donor HLA class I-specific manner. CONCLUSIONS/
INTERPRETATION: These data demonstrate the simultaneous presence of regulatory and effector T cells in the pancreas allograft of a recipient with type 1 diabetes. They also indicate that circulating islet autoreactive T cells may reflect immunological processes in pancreatic tissue, even though their frequency in the periphery may lead to underestimation of their presence in the pancreas. Additional specificities were also present in the pancreas that were undetectable in the circulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104770     DOI: 10.1007/s00125-008-1237-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.

Authors:  James E Greening; Timothy I M Tree; Karolena T Kotowicz; Astrid G van Halteren; Bart O Roep; Nigel J Klein; Mark Peakman
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

Review 2.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

Review 3.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

Authors:  M A Atkinson; G S Eisenbarth
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

4.  Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Authors:  Sally C Kent; Yahua Chen; Lisa Bregoli; Sue M Clemmings; Norma Sue Kenyon; Camillo Ricordi; Bernhard J Hering; David A Hafler
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.

Authors:  Gabrielle G M Pinkse; Odette H M Tysma; Cees A M Bergen; Michel G D Kester; Ferry Ossendorp; Peter A van Veelen; Bart Keymeulen; Danny Pipeleers; Jan W Drijfhout; Bart O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

6.  HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65.

Authors:  Timothy I M Tree; Gaby Duinkerken; Sabine Willemen; René R P de Vries; Bart O Roep
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

7.  Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells.

Authors:  Z Liu; S Tugulea; R Cortesini; N Suciu-Foca
Journal:  Int Immunol       Date:  1998-06       Impact factor: 4.823

Review 8.  Transplantation for the treatment of type 1 diabetes.

Authors:  R Mark Meloche
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

9.  Regulatory CD8+CD28- T cells in heart transplant recipients.

Authors:  Adriana I Colovai; Mansoor Mirza; George Vlad; S u Wang; Eric Ho; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Hum Immunol       Date:  2003-01       Impact factor: 2.850

10.  Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.

Authors:  Volkert A L Huurman; Robert Hilbrands; Gabriëlle G M Pinkse; Pieter Gillard; Gaby Duinkerken; Pieter van de Linde; Petronella M W van der Meer-Prins; Minke F J Versteeg-van der Voort Maarschalk; Koen Verbeeck; Behrooz Z Alizadeh; Chantal Mathieu; Frans K Gorus; Dave L Roelen; Frans H J Claas; Bart Keymeulen; Daniel G Pipeleers; Bart O Roep
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  24 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

2.  Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology.

Authors:  Ken T Coppieters; Bart O Roep; Matthias G von Herrath
Journal:  Semin Immunopathol       Date:  2010-12-18       Impact factor: 9.623

Review 3.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes.

Authors:  Bart O Roep; Nanette Solvason; Peter A Gottlieb; Joana R F Abreu; Leonard C Harrison; George S Eisenbarth; Liping Yu; Michael Leviten; William A Hagopian; John B Buse; Matthias von Herrath; Joanne Quan; Robert S King; William H Robinson; Paul J Utz; Hideki Garren; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

Review 5.  Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.

Authors:  Fanny Buron; Sophie Reffet; Lionel Badet; Emmanuel Morelon; Olivier Thaunat
Journal:  Curr Diab Rep       Date:  2021-04-25       Impact factor: 4.810

6.  T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Authors:  Dennis X Beringer; Fleur S Kleijwegt; Florian Wiede; Arno R van der Slik; Khai Lee Loh; Jan Petersen; Nadine L Dudek; Gaby Duinkerken; Sandra Laban; Antoinette Joosten; Julian P Vivian; Zhenjun Chen; Adam P Uldrich; Dale I Godfrey; James McCluskey; David A Price; Kristen J Radford; Anthony W Purcell; Tatjana Nikolic; Hugh H Reid; Tony Tiganis; Bart O Roep; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

7.  Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.

Authors:  K Åkesson; A Tompa; A Rydén; M Faresjö
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

8.  Islet inflammation and CXCL10 in recent-onset type 1 diabetes.

Authors:  B O Roep; F S Kleijwegt; A G S van Halteren; V Bonato; U Boggi; F Vendrame; P Marchetti; F Dotta
Journal:  Clin Exp Immunol       Date:  2010-01-05       Impact factor: 4.330

Review 9.  Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.

Authors:  Jane H Buckner; Gerald T Nepom
Journal:  J Autoimmun       Date:  2016-03-03       Impact factor: 7.094

10.  Phagocytosis of enterovirus-infected pancreatic beta-cells triggers innate immune responses in human dendritic cells.

Authors:  Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.